United Kingdom Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-09-10
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-united-kingdom
United Kingdom Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-09-10: 10Y at 5.68%, fitted curve 6M–30Y (4.61%–6.16%), 60 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 6M | 4.61% | — |
| 9M | 4.64% | 4.80% |
| 12M | 4.68% | 4.80% |
| 18M | 4.75% | 4.95% |
| 2Y | 4.81% | 5.09% |
| 3Y | 4.95% | 5.31% |
| 4Y | 5.08% | 5.58% |
| 5Y | 5.20% | 5.84% |
| 6Y | 5.31% | 6.07% |
| 7Y | 5.42% | 6.28% |
| 8Y | 5.51% | 6.46% |
| 9Y | 5.60% | 6.62% |
| 10Y | 5.68% | 6.74% |
| 15Y | 5.95% | 6.94% |
| 20Y | 6.08% | 6.97% |
| 25Y | 6.14% | 6.82% |
| 30Y | 6.16% | 6.65% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.81% and the 10-year 5.68%, a 10Y−2Y spread of +86 bp — positively sloped — as of 2026-09-10. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-10 | 1m ago2026-08-11 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-13 | 5m ago2026-04-13 | 6m ago2026-03-13 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.81% | 4.59% | 4.57% | 4.40% | 4.32% | 4.18% | 3.96% |
| 10Y | 5.68% | 5.45% | 5.27% | 5.23% | 5.10% | 4.98% | 5.03% |
| 10Y − 2Y | +86 bp | +86 bp | +70 bp | +83 bp | +78 bp | +80 bp | +107 bp |
Bonds in this curve
A selection of 30 of the 65 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Astrazeneca PLC | 4.64% | 2027-02-26 | 4.80% | US04636NAK90 |
| Glaxosmithkline Capital | 4.48% | 2027-03-12 | 4.32% | US377373AM70 |
| CSL Finance PLC | 4.71% | 2027-04-27 | 3.85% | US12661PAA75 |
| Astrazeneca PLC | 4.47% | 2027-06-12 | 3.12% | US046353AN82 |
| Royalty Pharma PLC | 4.51% | 2027-09-02 | 1.75% | US78081BAJ26 |
| Astrazeneca PLC | 4.83% | 2028-03-03 | 4.88% | US04636NAF06 |
| Glaxosmithkline Capital | 4.77% | 2028-05-15 | 3.88% | US377372AN70 |
| Astrazeneca PLC | 4.70% | 2029-01-17 | 4.00% | US046353AT52 |
| Astrazeneca PLC | 4.88% | 2029-02-26 | 4.85% | US04636NAL73 |
| CSL Finance PLC | 5.23% | 2029-04-27 | 4.05% | USG2584CAB21 |
| Glaxosmithkline Capital | 4.93% | 2029-06-01 | 3.38% | US377373AH85 |
| Glaxosmithkline Capital | 5.11% | 2030-04-15 | 4.50% | US377372AP29 |
| Astrazeneca PLC | 4.98% | 2030-08-06 | 1.38% | US046353AW81 |
| Astrazeneca PLC | 5.21% | 2031-05-28 | 2.25% | US04636NAB91 |
| Royalty Pharma PLC | 5.41% | 2031-09-02 | 2.15% | US78081BAN38 |
| CSL Finance PLC | 5.50% | 2032-04-27 | 4.25% | USG2584CAC04 |
| Astrazeneca PLC | 5.32% | 2033-03-02 | 4.30% | US04636NAR44 |
| Astrazeneca PLC | 5.41% | 2034-02-26 | 5.00% | US04636NAN30 |
| Smith & Nephew PLC | 5.74% | 2034-03-20 | 5.40% | US83192PAD06 |
| Glaxosmithkline Capital | 5.42% | 2034-04-15 | 5.38% | US377372AB33 |
| Glaxosmithkline Capital | 5.55% | 2035-04-15 | 4.88% | US377372AQ02 |
| Astrazeneca PLC | 5.47% | 2036-03-02 | 4.60% | US04636NAS27 |
| Astrazeneca PLC | 5.61% | 2037-09-15 | 6.45% | US046353AD01 |
| Glaxosmithkline Capital | 5.77% | 2038-05-15 | 6.38% | US377372AE71 |
| CSL Finance PLC | 6.12% | 2042-04-27 | 4.62% | US12661PAD15 |
| Astrazeneca PLC | 5.91% | 2042-09-18 | 4.00% | US046353AG32 |
| Astrazeneca PLC | 6.01% | 2045-11-16 | 4.38% | US046353AM00 |
| Astrazeneca PLC | 6.01% | 2048-08-17 | 4.38% | US046353AU26 |
| Astrazeneca PLC | 5.99% | 2050-08-06 | 2.12% | US046353AX64 |
| Royalty Pharma PLC | 6.39% | 2054-09-02 | 5.90% | US78081BAS25 |